Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycolysis pathway enzymes are a group of cytoplasmic enzymes that catalyze the sequential conversion of glucose into pyruvate through ten distinct steps. These include hexokinase/glucokinase, phosphoglucoisomerase, phosphofructokinase, aldolase, triose phosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, enolase, and pyruvate kinase[1][7]. The process generates ATP and NADH for cellular energy needs. Three key regulatory enzymes—hexokinase/glucokinase (step 1), phosphofructokinase (step 3), and pyruvate kinase (step 10)—control the overall flux through the pathway[1][5]. Dysregulation or mutation in these enzymes can lead to diseases such as hemolytic anemia or contribute to cancer cell proliferation via the Warburg effect[4]. Because many tumors rely heavily on aerobic glycolysis for growth even under oxygen-rich conditions ("Warburg effect"), several glycolytic enzymes are considered promising therapeutic targets in oncology[4].
Inhibition of enzymatic activity to block ATP production in cancer cells or pathogens Modulation of metabolic flux through the glycolytic pathway
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycolysis pathway enzyme.